HUTCHMED (China) Limited (HCM)
NASDAQ: HCM · Real-Time Price · USD
13.79
-0.06 (-0.43%)
Mar 9, 2026, 3:19 PM EDT - Market open
HUTCHMED (China) Market Cap
HUTCHMED (China) has a market cap or net worth of $2.46 billion as of March 9, 2026. Its market cap has decreased by -7.79% in one year.
Market Cap
2.46B
Enterprise Value
1.21B
1-Year Change
-7.79%
Ranking
Category
Stock Price
$13.79
Market Cap Chart
Since March 17, 2016, HUTCHMED (China)'s market cap has increased from $1.60B to $2.46B, an increase of 54.26%. That is a compound annual growth rate of 4.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 2.42B | 3.93% |
| Dec 31, 2025 | 2.33B | -7.42% |
| Dec 31, 2024 | 2.51B | -19.95% |
| Dec 29, 2023 | 3.14B | 22.75% |
| Dec 30, 2022 | 2.56B | -50.05% |
| Dec 31, 2021 | 5.12B | 19.79% |
| Dec 31, 2020 | 4.27B | 27.79% |
| Dec 31, 2019 | 3.34B | 8.92% |
| Dec 31, 2018 | 3.07B | -35.89% |
| Dec 29, 2017 | 4.79B | 195.91% |
| Dec 30, 2016 | 1.62B | 1.27% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hims & Hers Health | 3.59B |
| Kiniksa Pharmaceuticals International, | 3.53B |
| Prestige Consumer Healthcare | 3.18B |
| Liquidia | 3.17B |
| Supernus Pharmaceuticals | 3.10B |
| BioCryst Pharmaceuticals | 2.13B |
| Bausch Health Companies | 1.99B |
| Phibro Animal Health | 1.94B |